Non-invasive blood glucose measurement by near infrared spectroscopy: Machine drift, time drift and physiological effect

Similar documents
Research of the Measurement on Palmitic Acid in Edible Oils by Near-Infrared Spectroscopy

For more information, please contact: or +1 (302)

Noninvasive Blood Glucose Analysis using Near Infrared Absorption Spectroscopy. Abstract

Address: Department of Biosystems, Faculty of Bioscience Engineering, Katholieke Universiteit Leuven KU Leuven, Kasteelpark Arenberg 30, B-3001

Artificial Neural Networks and Near Infrared Spectroscopy - A case study on protein content in whole wheat grain

Qingbo Li, Qishuo Gao, and Guangjun Zhang. 1. Introduction

BLOOD GLUCOSE LEVEL MONITORING BY NONINVASIVE METHOD USING NEAR INFRA RED SENSOR

Monitoring Tumor Therapy

Vidi A. Saptari. Submitted to the Department of Mechanical Engineering in partial fulfillment of the requirements for the degree of.

NEAR INFRARED TRANSMISSION SPECTROSCOPY AS APPLIED TO FATS AND OIL

Evaluation of Measurement Sites for Noninvasive Blood Glucose Sensing with Near-Infrared Transmission Spectroscopy

Non Invasive Estimation of Blood Glucose using Near Infra red Spectroscopy and Double Regression Analysis

Temperature Effect on Near Infrared Spectrum of Glucose Monitoring

Design and Development of Non-Invasive Prototype to Measure Pulse Rate, Blood Glucose and Oxygen Saturation Level in Arterial Blood

pharmaceutical formulations. Anagliptin shows absorption maximum at 246 nm and obeys beer s law in the

1.4 - Linear Regression and MS Excel

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

DETECTION AND QUANTIFICATION OF STICKINESS ON COTTON SAMPLES USING NEAR INFRARED HYPERSPECTRAL IMAGES

Determination of Cannabinoid and Terpene Profiles in Cannabis Oils by Mid-Infrared Spectroscopy: 1. Cannabinoids

ScienceDirect. Comparative Study of Different Measurement Sites using NIR Based Non-invasive Glucose Measurement system

The challenges of analysing blood stains with hyperspectral imaging

Food protein powders classification and discrimination by FTIR spectroscopy and principal component analysis

FreeStyle Lite A Blood Glucose Meter That Requires No Coding

Use of Near Infrared Analysis for the Evaluation of Rice Quality. Glenn Merberg, Ph.D. B. Raymond Oberg

Bern Harrison, B.A., Cheryl Leazenby, B.S., and Solveig Halldorsdottir, Ph.D.

Milled Rice Surface Lipid Measurement by Diffuse Reflectance Fourier Transform Infrared Spectroscopy (DRIFTS)

Determining the Concentration of Iron in Vitamin Supplements

Development of near-infrared absorption spectrometry system by using NIR wideband glass phosphor LED

Biocard. 1. Troponin I

A MODULAR APPROACH TO DIABETIC EXAMINATION WITH ALERT SYSTEM BASED ON

Soy Lecithin Phospholipid Determination by Fourier Transform Infrared Spectroscopy and the Acid Digest/Arseno-Molybdate Method: A Comparative Study

Method Development and Validation of Emtricitabine in Bulk by UV Spectroscopy

Muscle OxyGen monitor. The Science Behind Moxy

Non Invasive methods of Hemoglobin

Prediction of blood β-hydroxybutyrate content in early-lactation New Zealand dairy cows using milk infrared spectra

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

In vivo Infrared Spectroscopy

4. VISIBLE SPECTROPHOTOMETRIC DETERMINATION OF. Fulvestrant is primarily used in the treatment of hormone receptor

AS and A-level Biology: Answers to activities in Transition guide

Rapid Determination of cis and trans Content, Iodine Value, and Saponification Number of Edible Oils by Fourier Transform Near-Infrared Spectroscopy

Figure 2.1: Glucose meter

Department of Chemistry, School of Science, Kwansei-Gakuin University, Uegahara, Nishinomiya , Japan

Competitive Intelligence Report Technology & Patents

Validated UV Spectrophotometric Method Development And Stability Studies Of Acamprosate Calcium In Bulk And Tablet Dosage Form

Spectral Imaging as a Modern Tool for Medical Diagnostics

Rapid Quality Measurements of Flour and Wheat in the Milling industry. Phillip Clancy, Next Instruments, Australia.

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

Estimation of protein using standard curve & Biochemistry analyzer. Experiment 1 & 2 BBT 314 ACh

The present manuscript describes simple, sensitive, rapid, accurate, precise and cost effective First derivative

Clinical Evaluation for. Embrace No Code Blood Glucose Monitoring System

Manipulating Diabetes by Mooting Blood Clott Time Parameter

Analysis of Common Sweeteners and Additives in Beverages with the PerkinElmer Flexar FX-15 System Equipped with a PDA Detector

UV Spectrophotometric Estimation of Alprazolam by Area Under Curve And First Order Derivative Methods in Bulk and Pharmaceutical Dosage Form

Clinically Available Optical Topography System

Determination of the Diffusion Coefficient for Sucrose in Aqueous Solutions

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Development and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen sodium in tablet dosage form

A study on the transmittivity of Tyvek

Trans Fat Determination in the Industrially Processed Edible Oils By Transmission FT-IR Spectroscopy By

In-Vitro Bioequivalence Studies for Oral Solid Dose products using the Morphologi G3-ID

The use of a hand-held mid-infrared spectrometer for the rapid prediction of total petroleum hydrocarbons in soil

Determination of Free Fatty Acids in Crude Palm Oil and Refined-Bleached-Deodorized Palm Olein Using Fourier Transform Infrared Spectroscopy

CHAPTER 4 EFFECT OF OXALIC ACID ON THE OPTICAL, THERMAL, DIELECTRIC AND MECHANICAL BEHAVIOUR OF ADP CRYSTALS

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

Introduction. Cell Biology OLM

DEVELOPMENT AND VALIDATION OF SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF METOPROLOL SUCCINATE

DEVELOPMENT AND VALIDATION OF COLORIMETRIC METHODS FOR THE DETERMINATION OF RITONAVIR IN TABLETS

DEVELOPMENT AND VALIDATION OF AN UV- SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF FLUOXETINE IN PURE AND TABLET DOSAGE FORMS

Measurement of Acrylamide in Potato Chips by Portable FTIR Analyzers

Fluorescent Carbon Dots as Off-On Nanosensor for Ascorbic Acid

Development of an Optical Sensor Based System for Detection and Monitoring of Hemoglobin in Blood

There are many varieties of particulate pollutants in our homes and offices. Ones from outside include industrial

DESIGN OF AUTOMATIC INSULIN DOSAGE INDICATOR FOR DIABETIC PATIENTS USING BMI

Determination of flavonoids and phenolic acids in the extract of bamboo leaves using near-infrared spectroscopy and multivariate calibration

Journal of Chemical and Pharmaceutical Research

Noninvasive near infrared spectroscopy on living tissue with multivariate calibration approaches

The optimization of FTIR spectroscopy combined with partial least square for analysis of animal fats in quartenary mixtures

Smart Probe for Uric Acid Detection

NIR Red Models for Estimation of Chlorophyll a Concentration Application to Aircraft and Satellite Data

FreeStyle Mini Blood Glucose Results Are Accurate and Suitable for Use in Glycemic Clamp Protocols

Nocturnal hypoglycemic alarm based on nearinfrared

International Journal of Drug Research and Technology

Development and validation of UV-visible spectrophotometric method for estimation of rifapentine in bulk and dosage form

Spectrophotometric Method for Estimation of Sitagliptin Phosphate in Bulk...

Body in a Lab: Aspirin Overdose

Available online Research Article

Engineering the Growth of TiO 2 Nanotube Arrays on Flexible Carbon Fibre Sheets

Fast, Simple QA/QC of Milk Powder Formulations using FTIR Spectroscopy. Rob Wills Product Specialist Molecular Spectroscopy

Available Online through Research Article

ssociation of Children s Diabetes Clinicians Clinicians Continuous Glucose Monitoring (CGM) Training for Healthcare Professionals and Patients

An in vitro hemodynamic tissue model to study the variations in flow using near infrared spectroscopy

The determination of total N, total P, Cu and Zn in chicken manure using near infrared reflectance spectroscopy

MAKING IT HAPPEN: NIR CALIBRATION TRANSFER

Biomedical Sensing Application of Raman Spectroscopy. Yukihiro Ozaki Kwansei Gakuin University

Chunyang Ding. A Sweet Conclusion: Comparing the Osmotic Potentials of Yams and Sweet Potatoes. 2 October Mr. Allen. AP/IB Biology P.

Characteristics of PMT used in prototype array of ED

210 J App Pharm Vol. 6; Issue 2: ; April, 2014 Mustafa et al, 2014

FT-Raman Surface Mapping of Remineralized Artificial Dental Caries

Transcription:

Spectroscopy 24 (2010) 629 639 629 DOI 10.3233/SPE-2010-0485 IOS Press Non-invasive blood glucose measurement by near infrared spectroscopy: Machine drift, time drift and physiological effect Simon C.H. Lam, Joanne W.Y. Chung, K.L. Fan and Thomas K.S. Wong School of Nursing, The Hong Kong Polytechnic University, Hong Kong, China Abstract. The aim of this paper is to evaluate development of the non-invasive blood glucose measurement of near infrared (NIR) spectroscopy. The results showed that NIR spectroscopy might obtain glucose concentration of up to 200% difference under a same environmental condition with two months apart due to time and machine drifts. These effects can restrict the development of the non-invasive blood glucose measurement. Partial least square (PLS) regression was used, which showed advantage over using simple absorbance for glucose concentration. Non-invasive blood glucose measurement of health subjects (non-diabetics) was also investigated. The results showed that R correlation coefficient of prediction (R p) was 0.48 and root mean square of prediction (rmsep) was 1.34 mmol/l. The error was mainly due to the physiological effect of different subjects. Keywords: Spectroscopy, machine drift, time drift, physiological effect, PLS, PDS, Beer s law 1. Introduction Diabetes mellitus (DM) is a chronic and incurable disease caused by the malfunction of insulin production which affects the blood glucose [1,8,10] in the body, normally leading to hyperglycemia. Prolonged hyperglycemia causes damage to nerves and blood vessels [1,8,10], which may cause many complications. Thus, the role of blood glucose monitoring and measurement becomes very important for diabetic therapies. 1.1. Diabetes The number of diabetics is increasing. According to World Health Organization (WHO), there were 171 million people with DM worldwide [6,11]. In the year 2030, the number of diabetics may reach to 366 million, of which 90 95% will suffer from Type 2 diabetes [6,9]. The highest prevalence was in the developing countries, India and China (20.8 million) in the year 2000 [6]. It is predicted that the number of the diabetics will significantly increase to 42.3 million in China after 30 years [6]. Finger-prick glucose measurements are common and can provide reliable glucose readings. They do not continuously monitor blood glucose and therefore cannot present a precise glucose trend. In addition, since blood samples are needed for the glucose measurement, this repeated sampling causes pain and damage to the skin tissue, which may raise the chance of infection. * Corresponding author: Simon C.H. Lam, School of Nursing, The Hong Kong Polytechnic University, Hong Kong, China. Tel.: +852 8210 0441; Fax: +852 8210 0517; E-mail: simon-lam@live.com. 0712-4813/10/$27.50 2010 IOS Press and the authors. All rights reserved

630 S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy A non-invasive approach is the painless method for blood glucose measurement. However, no noninvasive blood glucose meter currently in use has provided consistently reliable results, due to many interfering non-specific physiological signals during the measurement (especially for long-term measurement). According to Danzer et al. [3], the long-term unreliability might be due to the physiological differences amongst subjects and time drift factors. Thus, diabetic patients still need to rely on painful finger-prick sampling for daily glucose measurement. 2. Experiment and clinical trial An experiment by using glucose solutions (see Fig. 1) and a clinical trial with healthy subjects had been conducted. 2.1. Glucose solutions Control Development s NIR spectrometer of NIR-128L-1.7-USB, with the wavelength range of 905 1701 nm was used. D-Glucose dissolved in deionised water was used for preparing different glucose concentrations. A thermo-resistant petri dish made of polystyrene (PS) was used as the container because of its high temperature resistance and good optical clarity. The known concentrations of solutions were measured by NIR spectrometer in a room with a temperature range of 24 25 C and a relative humidity of 55 60%. Four sets of glucose solution measurements, each set with five concentrations (0, 125 250, 500 and 1000 mmol/l), were measured on three separate days by NIR spectroscopy. The average of the NIR spectra was recorded from 64 readings per sample. Calibration against the background and the reference (under tungsten halogen light) was carried before each glucose measurement. 2.2. Clinical trial Thirty-six healthy subjects voluntarily joined the clinical trial and had been fasting overnight before the first NIR and the first finger-prick glucose measurement in the morning. The subject group comprised eight males and 28 females, all of whom were non-diabetic. Finger pricks and NIR measurements were performed at the preprandial (fasting stage) and again at the postprandial (after had breakfast) stage. The whole procedure for data capture (including NIR spectra, finger surface temperature and finger-prick glucose levels) took approximately 3 5 min, per patient. Each subject was provided the same breakfast at the same quantity after the preprandial measurement. A sucrose candy had also been provided for each subject 15 30 min before the postprandial measurements. This helped to increase their respective glucose level, thus the glucose levels would be varied. Fig. 1. Block diagram glucose concentration analysis.

3. Analytical methods S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy 631 According to Beer s law, the absorbance is related to the concentration. Thus, based on Beer s law, a single wavelength was selected for the glucose concentration evaluation. Another technique of partial least square (PLS) prediction [4,7] was also applied for the analysis. One group of data from two different experiments were used for calibrations, another one was for prediction and validation purposed as shown in Fig. 2. The spectra obtained were separated into two groups. One group (Spectra A) was used for calibration with the corresponding glucose concentrations and formed the calibration model (Model) shown on Eqs (1) and (2). g 1 = M 1 X 1 + e 1, (1) where X 1 Spectra A, e 1 error 1, g 1 corresponding glucose concentrations, M 1 calibration model built. Then, Spectra B were substituted to M 1 by PLS. g = M 1 X 2 + e 2, (2) where X 2 Spectra B, e 2 error 2, g predicted glucose concentrations. The predicted glucose concentrations g were then validated with g 2,whereg 2 was the glucose concentration corresponding to Spectra B. 4. Results and discussions 4.1. Glucose solutions The results showed that pure water provided a higher absorbance spectrum. Lower absorbance spectra represented higher glucose concentrations as shown in Fig. 3. The wavelength 1180 nm was chosen for the analysis, as it showed the most clearly distinguished absorbance and was also located in the region of second overtones [5]. Fig. 2. Block diagram PLS prediction process of glucose solution concentration.

632 S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy Fig. 3. NIR spectra glucose solutions, absorbance against wavelength (nm). Day 1 under room condition. (Colors are visible in the online version of the article; http://dx.doi.org/10.3233/spe-2010-0485.) 4.2. Glucose solutions measurement on the same day Different batches of glucose solutions were measured within one hour by NIR spectroscopy. These measurements were used to check the reliability of the NIR measurement within a short period of time, while trying to avoid machine drift and time drift. The glucose concentration was first plotted against the NIR absorbance spectra. 4.3. Single wavelength absorbance vs. glucose concentration Inverse linearity was observed with absorbance spectra at wavelength 1180 nm, where the lower absorbance indicated a higher glucose concentration. The best fitted lines, shown in Fig. 4, can be represented by the following linear equations, respectively.

S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy 633 Fig. 4. Absorbance at 1180 nm against glucose concentration, separated experiment in one hour; fit of Day 3a is close to fit of Day 3b. (Colors are visible in the online version of the article; http://dx.doi.org/10.3233/spe-2010-0485.) Fit 3a: y = 5.19e 5 x + 0.47 (R = 0.91 and RMSE = 0.0108 AU or 207 mmol/l). (3) Fit 3b: y = 4.84e 5 x + 0.46 (R = 0.87 and RMSE = 0.0098 AU or 204 mmol/l), (4) where y absorbance units, x glucose concentrations, R R correlation coefficient, RMSE root mean square error. Figure 4 showed that the fit of 3a and 3b were close to each other. This showed that the results of the two experiments were nearly repeated. This also demonstrated that glucose concentrations could be measured via transmittance NIR spectroscopy, where the absorbance (AU) is related to the glucose concentrations. 4.4. Glucose concentration predictions by PLS PLS is another prediction technique mainly used for spectroscopic application. The spectral results were analyzed by PLS. The known glucose concentrations were calibrated with the measured spectra from Day 3a to form a model and then the measured spectra of Day 3b (after one hour) were predicted through PLS. Figure 5 shows the scatter plot of the calibration results and the prediction results of the glucose concentration within one hour. These results showed the R correlation coefficient of the prediction R p = 0.92 and root mean square error rmse = 158 mmol/l. The relationship between spectral signals (or the absorbance unit under

634 S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy Fig. 5. PLS prediction scatter plot, separated experiment in the same day within one hour; cross ( ) calibration; hollow ( ) prediction. (Colors are visible in the online version of the article; http://dx.doi.org/10.3233/spe-2010-0485.) tungsten halogen at 1180 nm wavelength) and the glucose concentration was linear. The major predicted error occurred in the low glucose range. PLS provides another prediction technique for the glucose concentrations by using NIR spectroscopy. The poorest prediction was located in the pure water region. PLS prediction provided partly poorer results when compared with the direct absorbance to the glucose concentration analysis. However, the prediction made through PLS was still better than just using the absorbance unit. Although glucose concentration is proportional to the NIR absorbance of a single wavelength, the rate of error may be higher when only a single wavelength is used. Alternatively, PLS was applied by using the whole range of the spectra for the prediction. The error may be relatively small since used whole range spectra may cause to average the error. 4.5. Glucose solution measurements on different days Different batches of known glucose solutions were measured on different days (two month apart) by the same NIR spectrometer. The glucose concentration was plotted against NIR absorbance for the evaluation. It was also analyzed by PLS. 4.6. Single wavelength absorbance versus glucose concentration on separate days Absorbance of the single wavelength at 1180 nm was plotted against the corresponding glucose concentration, as shown in Fig. 6. The results showed that the data of Day 1 is about 0.06 AU (potentially a very significant error) higher than the data of Day 2. Their fitting equations are shown below. Fit 1: y = 3.32e 5 x + 0.47 (R = 0.99 and RMSE = 0.0020 AU or 60 mmol/l). (4-5)

S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy 635 Fig. 6. Absorbance at 1180 nm against glucose concentration, two experiments in two months separation (with two preparations for same concentrations). (Colors are visible in the online version of the article; http://dx.doi.org/10.3233/spe-2010-0485.) Fit 2: y = 3.23e 5 x + 0.41 (R = 0.91 and RMSE = 0.0052 AU or 163 mmol/l), (4-6) where y absorbance units, x glucose concentrations, R R correlation coefficient, RMSE root mean square error. 0.06 AU represents 2000 mmol/l. This showed that the results might not be reproducible under a single wavelength measurement after two months. This was due to machine drift and time drift. Even though there was only one variable glucose, the machine might face micro-deviation among the different inner parts which accumulated over a period of time. 4.7. Spectra prediction versus glucose concentration by PLS on separate days Preprocess of Piecewise Direct Standardization (PDS) was used to regulate the spectral drifts from different days. These preprocessed data were then calibrated and predicted by PLS regression. The results were then scatter plotted, as shown in Fig. 7. The results showed that R p = 0.97 and rmsep = 144 mmol/l. A major error also occurred in the low glucose concentration region, particularly for the pure water measurement. Table 1 shows the summary of R and rmse (R p and rmsep) by absorbance and PLS spectral analysis, respectively. 5. Error and noise There were possible measurement errors, or noises, of the glucose solution. The experiment was carried out under the exposure to the surrounding environment. The results might not be affected by the

636 S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy Fig. 7. PLS prediction scattered plot, separated experiment in different days in two month: cross ( ) calibration; hollow ( ) prediction. (Colors are visible in the online version of the article; http://dx.doi.org/10.3233/spe-2010-0485.) Table 1 R correlation of coefficient and rmse (root mean square error) comparison; absorbance of Day 1 > 0.06 AU of absorbance of Day 2 Analysis Day Under same day Under different days R RMSE (mmol/l) R RMSE (mmol/l) Absorbance 0.91 207 0.99 (Day 1) 60 (Day 1) 0.87 204 0.91 (Day 2) 163 (Day 2) PLS (prediction) R p = 0.92 rmsep = 158 R p = 0.97 rmsep = 144 surrounding florescent light which exists at 190 nm to 650 nm, while NIR is ranged from 730 nm to 2500 nm. The indium gallium arsenide (InGaAs) detector (NIR detector could only sense within NIR region) of the spectrometer was not affected by the surrounding visible light. However, NIR might have derived from other NIR environmental sources, such as temperature variations, if some of the other equipment present generated an NIR wavelength range. In addition, the resolution of the spectrometer is 6.22 nm, thus, the specificity of the absorbance at 1180 nm could be 1180 ± 6.22 nm. The results might not really represent the absorbance of the exact corresponding wavelength. However, NIR overtones always overlaps to multiple wavelengths or a certain range of the spectrum (83). The separation of each measurement pixel forms the spectrum by interpolation. This indicates that the resolution might not provide a significant effect to the absorbance. Unless there was a particular wavelength that had fallen in between two pixels, error might happen. However, as NIR overtones always cover multiple wavelengths, the resolution of the absorbance was enough to cover the measurement.

S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy 637 Nevertheless, the measurement area in the experiment was relatively large within the petri dish, and it might affect the results, particularly on the low glucose concentration. The glucose particles might not be equally distributed among the large area. The error could be relatively large due to the outside environment and the glucose preparation error, particularly in low glucose concentration areas. 5.1. Clinical trial A total of 108 sets of spectra were obtained. Thirty-six sets of spectra were obtained before breakfast. Seventy-two sets of spectra (where one additional set of spectra was obtained from each subject in postprandial measurement) were obtained after breakfast. Figure 8 shows a spectral plot of absorbance against wavelength. The spectra were similar to those shown in Fig. 3. Overtones also occurred on 980 nm and 1200 nm. PLS was applied for the prediction (each third of the data of the spectra and the corresponding glucose readings were used for prediction, while the remaining sets of data were used for calibration). Results are presented in the scatter plot shown in Fig. 9. Figure 9 showed that both the calibrations and predictions were located within the clinical, acceptable regions, A and B. The R correlation coefficient of the calibration (R c ) was 0.85 and the root mean square Fig. 8. Absorbance against wavelength, healthy subject. (Colors are visible in the online version of the article; http://dx.doi.org/ 10.3233/SPE-2010-0485.)

638 S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy Fig. 9. Scatter plot of predicted against finger-prick blood glucose level with simple mean-centred preprocess and PDS preprocess, for full wavelength and non-arranged data: ( ) calibration, ( ) prediction. (Colors are visible in the online version of the article; http://dx.doi.org/10.3233/spe-2010-0485.) error of calibrations (rmsec) was 0.57 mmol/l. The R correlation coefficient of the prediction (R p )was 0.48. The root mean square error of prediction (rmsep) was 1.34 mmol/l. Most of the prediction spots fell in Region A, where errors were within 20%. Regions A and B were clinically acceptable regions as stated by Clarke Grid Error plot [2]. This demonstrated that NIR spectra and the blood glucose levels of non-diabetics were correlated after applying PLS for the prediction. The results showed that the study of non-diabetics provided a positive sign for non-invasive blood glucose prediction. However, high variation as shown in Fig. 8 may lead to difficulties for blood glucose prediction. The spectral variation might indicate that higher noises or uncertainty of signals might be obtained in addition to the necessary signals. This might be due to time drift, machine drift and physiological differences in a long-term clinical measurement. The physiological influence from the human body was one of the key effects in relation to non-invasive blood glucose measurement. Time factors have led to uncertain physiology, which could affect the prediction. The longer time span between each measurement, the more uncertainties due to the physiology occur; thus, the poorer the calibration and the prediction obtained. This is because of the higher chance of the reaction of the human body to both internal and external environmental changes. Therefore, the study of healthy subjects in short-term might have provided better predictions due to the shorter time span and relatively fewer physiological uncertainties. However, R p and rmsep were 0.48 and 1.34 mmol/l, respectively. This was because of physiological uncertainties between subjects.

S.C.H. Lam et al. / Non-invasive blood glucose measurement by near infrared spectroscopy 639 These two studies showed that time and machine drifts and physiological effect could affect in vivo blood glucose prediction. However, as mentioned, the glucose solution experiment showed that machine drift and time drift could be reduced by using PLS with preprocess. Thus, the error might be due to physiological differences between subjects. Furthermore, the results of this clinical trial also showed that the larger variation caused larger error for PLS predictions. The large variation might have been due to the physiological influences, including temperature. Thus, NIR measurement also needed to be improved by reducing the variation during the measurements. 6. Conclusions Results showed that higher glucose concentration, the lower the spectral absorbance was in the spectrum. However, NIR spectroscopic measurements were deviated due to machine drift and the time drift after two months. This caused errors in the NIR spectroscopic measurements. These drifts could be reduced or eliminated by PLS technique. NIR spectroscopic measurement under PLS analysis showed promising results on the glucose solution test in both short- and long-term experiments. However, physiological effects are unpredictable and varied from time to time due to the human body s reaction to the environment. This led to the most uncertainty during the clinical trial. Thus, considering the physiological influence for NIR non-invasive blood glucose measurements would be needed. References [1] ADA, All about diabetes, American Diabetes Association, 2006, available at: http://www.diabetes.org/about-diabetes.jsp. [2] W.L. Clarke, D. Cox, L.A. Gonder-Frederick, W. Carter and S.L. Pohl, Evaluating clinical accuracy of systems for selfmonitoring of blood glucose, Diabetes Care 10 (1987), 622 628. [3] K. Danzer, C. Fischbacher, K.U. Jagemann and K.J. Reichelt, Near-infrared diffuse reflection spectroscopy for noninvasive blood-glucose monitoring, IEEE 12(2) (1998), available at: http://www.ieee.org/organizations/pubs/newsletters/ leos/apr98/monitoring.htm. [4] S. de Jong, SIMPLS: An alternative approach to partial least squares regression, Chemometrics and Intelligent Laboratory Systems 18 (1993), 251 263. [5] B. Jorgensen and Y. Goegebeur, Multivariate Data Analysis and Chemometrics, Department of Statistic, University of Southern Denmark, Denmark, 2006. [6] W. Sarah, R. Sicree, G. Roglic, H. King and A. Green, Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030, Diabetes Care 27 (2004), 1047 1053. [7] R.D. Tobias, An introduction to partial least squares regression, SAS Institute Inc., Cary, NC, USA, 1998, available at: http://support.sas.com/rnd/app/papers/pls.pdf. [8] WHO, Diabetes mellitus, World Health Organization Media Center, April 2002, Fact Sheet No. 138. [9] WHO, Screening for type 2 diabetes, World Health Organization, 2003. [10] WHO, Diabetes programme: What is diabetes?, World Health Organization, 2006, available at: http://www.who.int/ diabetes/booklet_html/en/index4.html. [11] WHO, Diabetes programme: A rising global burden, World Health Organization, 2006.